hnRNPA2B1 induces HBV cccDNA degradation by recruiting APOBEC3B

Read full text
Authors: Zhendong Fu, Liyuan Wang, Yang Sun, Caiyue Ren, Yutong Dou, Kai Wang, Yuchen Fan, Xuetian Yue, Chunyang Li, Lifen Gao, Xiaohong Liang, Chunhong Ma
+1 more Zhuanchang Wu
Cited by: 2
References: 49

Abstract

Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) constitutes a viral persistence reservoir that sustains chronic infection. Although the DNA damage response (DDR) facilitates cccDNA biogenesis, its role in regulating cccDNA stability remains unclear. By intersecting published cccDNA-associated proteomic datasets with known DDR-related host factors, we identified heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) as a novel restriction factor that binds cccDNA and suppresses HBV replication by promoting cccDNA degradation. Mechanistically, hnRNPA2B1 interacted with the G-quadruplex (G4) structure of cccDNA, with preference for G4-1, G4-7, and G4-10, and leads to the recruitment of the cytidine deaminase APOBEC3B by its prion-like domain (PrLD), thereby inducing C>T and G>A hypermutations and initiating cccDNA decay. Notably, HBV counteracts this defense mechanism through HBx-mediated hnRNPA2B1 polyubiquitination and proteasomal degradation, revealing a viral evasion strategy that perpetuates cccDNA persistence. These findings reveal a G4-dependent surveillance axis wherein hnRNPA2B1 directs APOBEC3B-mediated cytidine deamination to destabilize cccDNA while identifying HBx-induced hnRNPA2B1 ubiquitination as a viral countermeasure. This mechanistic duality not only elucidates a critical virus-host interaction governing cccDNA persistence but also provides a promising therapeutic target for the treatment of HBV infection.

Fields of Study & Subjects

Hepatitis B Virus Studies HIV Research and Treatment HIV/AIDS drug development and treatment

Publication details

Journal / source
Nucleic Acids Research
Publisher
Oxford University Press (OUP)
Volume
54
Issue
5
Publication date
11 February 2026
Language
EN